Aspirin and Cardiovascular Risk in Individuals With Elevated Lipoprotein(a): The Multi-Ethnic Study of Atherosclerosis.

Harpreet Singh Bhatia Patrick J Trainor Samantha M Carlisle Michael Y Tsai Michael H CriquiAndrew DeFilippisSotirios Tsimikas

Published in: Journal of the American Heart Association (2024)

Aspirin use was associated with a significantly lower risk for CHD events in participants with lipoprotein(a) >50 mg/dL without baseline CVD. The results of this observational propensity-matched study require confirmation in studies with randomization of aspirin use.

Keyphrases

low dose
cardiovascular events
antiplatelet therapy
cross sectional
case control